mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0005 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.39 |
0.001 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |